Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.
Hosted on MSN19h
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here.Biotechnology is a high-risk, high-reward landscape where innovation determines success. Yet, occasionally, a small player ...
Invivyd has teamed up with professional football coach Jim Harbaugh to tackle COVID-19 complacency. The biotech, which has ...
Teaming up to raise awareness of the continuing toll of COVID-19 in America, an ongoing mass disabling event causing an American death ...
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
Invivyd (IVVD) announced a strategic partnership with professional football coach Jim Harbaugh to raise awareness about the ongoing short and ...
Harbaugh teamed up with Invivyd to encourage people to learn more about the symptoms of long COVID. Los Angeles Chargers head ...
Invivyd data shows strong potency and prolonged antibody levels in trials. Q4 Pemgarda revenue rose 48% to $13.8 million.
Invivyd is poised to support PEMGARDA commercial efforts and anticipates continued revenue growth along with operational efficiency improvements. Preliminary financial results are unaudited and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback